Company intelligence / Profile preview

Carlsquare

Ownership: Private
Development stage: Other

Overview

Carlsquare is a partner-led international investment bank specializing in M&A advisory, growth equity financing, IPO strategy, debt advisory services, and commissioned equity research. The firm has deep sector expertise across software, consumer goods, industrial technology—and notably life sciences including biotech, medtech, pharma services (CDMO/CRO), diagnostics & analytics. Carlsquare advises both private and public companies as well as investors on transactions ranging from acquisitions to capital raising. It does not itself develop drugs or medical products but regularly works with companies that do[1][4][5].

Industry: Consulting

Partnerships

Carlsquare partners with clients for financial transactions; it does not have pharmaceutical R&D partnerships but has advised on deals involving CDMOs like ROTOP Pharmaka and HKS health solutions[6][8].

Beyond the preview

Go deeper on Carlsquare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carlsquare.

Explore the full profile